Save $331
Description
BRUKINSA is a prescription medicine used to treat adults with:
- Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
- Waldenström’s macroglobulinemia (WM).
- Mantle cell lymphoma (MCL) who have received at least one prior treatment for their cancer.
- Marginal zone lymphoma (MZL) when the disease has come back or did not respond to treatment and who have received at least one certain type of treatment.
- Follicular lymphoma (FL), in combination with the medicine obinutuzumab, when the disease has come back or did not respond to treatment and who have received at least two prior treatments.
It is not known if BRUKINSA is safe and effective in children.
Additional information
| Brand | BRUKINSA |
|---|---|
| Generic name | Zanubrutinib capsules |
| Form | Oral capsules |
| Strength | 80mg |
| Packing | 120 capsules |
| Manufacturer | Catalent CTS |
| Documents | Either PO or prescription |
| Storage | Store at 20°C to 25°C |
Reviews
There are no reviews yet.